These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36921145)

  • 21. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?].
    Turan D; Aksaray S
    Mikrobiyol Bul; 2022 Jul; 56(3):493-505. PubMed ID: 35960240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints].
    Hazırolan G; Sarıbaş Z; Arıkan Akdağlı S
    Mikrobiyol Bul; 2016 Jul; 50(3):428-37. PubMed ID: 27525398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole.
    Marinach C; Alanio A; Palous M; Kwasek S; Fekkar A; Brossas JY; Brun S; Snounou G; Hennequin C; Sanglard D; Datry A; Golmard JL; Mazier D
    Proteomics; 2009 Oct; 9(20):4627-31. PubMed ID: 19750514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
    Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
    Lee JS; Shin JH; Lee K; Kim MN; Shin BM; Uh Y; Lee WG; Lee HS; Chang CL; Kim SH; Shin MG; Suh SP; Ryang DW
    Yonsei Med J; 2007 Oct; 48(5):779-86. PubMed ID: 17963334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
    Minea B; Nastasa V; Moraru RF; Kolecka A; Flonta MM; Marincu I; Man A; Toma F; Lupse M; Doroftei B; Marangoci N; Pinteala M; Boekhout T; Mares M
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):367-83. PubMed ID: 25224578
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Vatanshenassan M; Boekhout T; Meis JF; Berman J; Chowdhary A; Ben-Ami R; Sparbier K; Kostrzewa M
    Front Cell Infect Microbiol; 2019; 9():20. PubMed ID: 30834236
    [No Abstract]   [Full Text] [Related]  

  • 29. Machine Learning Approach for
    Delavy M; Cerutti L; Croxatto A; Prod'hom G; Sanglard D; Greub G; Coste AT
    Front Microbiol; 2019; 10():3000. PubMed ID: 32010083
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.
    Vatanshenassan M; Arastehfar A; Boekhout T; Berman J; Lass-Flörl C; Sparbier K; Kostrzewa M
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11.
    Maenchantrarath C; Khumdee P; Samosornsuk S; Mungkornkaew N; Samosornsuk W
    BMC Microbiol; 2022 Jun; 22(1):153. PubMed ID: 35689195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and antifungal susceptibility testing of non-albicansCandida species colonizing mucosae of HIV-infected patients in Yaoundé (Cameroon).
    Ngouana TK; Toghueo RMK; Kenfack IF; Lachaud L; Nana AK; Tadjou L; Kouanfack C; Boyom FF; Bertout S
    J Mycol Med; 2019 Sep; 29(3):233-238. PubMed ID: 31204235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and susceptibility profiles of oral yeast species isolated from a healthy adult Thai cohort.
    Pesee S; Samaranayake L; Roytrakul S; Paaopanchon C; Phantumvanit P
    Arch Oral Biol; 2022 Jun; 138():105415. PubMed ID: 35390561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing epidemiology of candidaemia in Australia.
    Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S;
    J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata.
    Vella A; De Carolis E; Mello E; Perlin DS; Sanglard D; Sanguinetti M; Posteraro B
    Sci Rep; 2017 Aug; 7(1):9099. PubMed ID: 28831086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China.
    Song Y; Liu X; Yang Z; Meng X; Xue R; Yu J; Al-Hatmi AMS; de Hoog GS; Li R
    Mycoses; 2021 Oct; 64(10):1261-1271. PubMed ID: 34173979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains.
    Haghani I; Yahyazadeh Z; Hedayati MT; Shokohi T; Badali H; Khojasteh S; Akhtari J; Javidnia J; Moazeni M; Al-Harrasi A; Aghili SR; Kermani F; Hajheydari Z; Al Hatmi AMS; Abastabar M
    Int J Antimicrob Agents; 2023 Mar; 61(3):106715. PubMed ID: 36640844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.